Robert O Dillman

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Immune Response

Peripheral Blood

Dendritic Cells

Coronavirus Disease

Top Venues

Human vaccines & immunotherapeutics

Melanoma management

AIVITA Biomedical, Inc.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AIVITA Biomedical, Inc. Jun 01 2016

United States

Chief Medical Officer :: Oncology

Publications

Robert O Dillman, Gabriel I Nistor, Hans S Keirstead
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines. Human vaccines & immunotherapeutics (2023)
Gabriel I Nistor, Robert O Dillman, Rockelle M Robles, James L Langford, Aleksandra J Poole, Muchlis A U Sofro, Yetty M Nency, Jonny Jonny, Martina L Yana, Mahammad Karyana, Endang S Lestari, Ria Triwardhani, Mujahidah Mujahidah, Retty K Sari, Nur A Soetojo, Djoko Wibisono, Daniel Tjen, Taruna Ikrar, Gregory Sarkissian, Haryono Winarta, Terawan A Putranto, Hans S Keirstead
A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses. Human vaccines & immunotherapeutics (2022)
Robert O Dillman
An update on GM-CSF and its potential role in melanoma management. Melanoma management 7 (3) (2020)
Robert O Dillman, Gabriel I Nistor, Aleksandra J Poole
Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine. Human vaccines & immunotherapeutics 16 (4) (2019)